Shares of the telehealth platform provider have tumbled since the company's successful stock market debut in September.
News & Analysis: AmWell
Investors can get squeamish at the sight of red ink.
AMWL earnings call for the period ending September 30, 2020.
The pandemic's worsening trends favor these businesses.
Both telehealth companies have seen growth accelerate during the pandemic, but your business philosophy may determine which stock is best for you.
The stock has doubled since its hot IPO, but coronavirus-induced trends might not be enough to satisfy investors seeking outsized gains.
It accuses its rival of nine violations related to two products.
Several analysts are giving the stock an enthusiastic thumbs-up.
Access to healthcare in America has changed, and these two companies could help you benefit.
Recently listed shares of the telehealth start-up recently jumped in response to speculation that America's largest health insurer was considering an acquisition.